查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1605699

联网给药设备市场，按产品类型、应用、给药途径、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Connected Drug Delivery Devices Market, By Product Type, By Application, Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年连网给药设备市场规模为 51,234.5 亿美元，2024 年至 2032 年复合年增长率为 23.5%。

联网给药设备市场-市场动态

对智慧高效给药解决方案的需求不断增长

糖尿病和气喘等慢性病的盛行率不断上升，推动了对连网药物输送设备的需求。这些设备透过数位平台提供即时监控、提醒和回馈，从而提高患者的依从性。人们对个人化医疗的认识不断提高，以及物联网在医疗保健领域的整合，进一步推动了它们的采用。无线连接和行动应用程式等技术进步透过为医疗保健专业人员提供远端监控来改善治疗结果。此外，对智慧医疗解决方案的投资不断增加以及对家庭护理的推动正在推动市场发展，满足全球对有效和高效的药物管理系统的需求。

互联药物输送设备市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 23.5% 左右的复合年增长率成长

根据产品类型细分，预计整合设备细分市场将在 2023 年呈现最大市场份额

从应用细分来看，2023年糖尿病细分市场为主导类型

按地区划分，北美是 2023 年的主要收入来源

连网给药设备市场細項分析：

全球连网药物输送设备市场根据产品类型、应用、给药途径和地区进行细分。根据产品类型，市场分为三类：独立组件和软体以及整合设备。整合设备领域在联网给药设备市场中占据主导地位。这些设备将药物输送机制与内建连接功能相结合，实现即时无缝追踪、监控和资料共享。它们的便利性、患者依从性的提高以及融入数位医疗系统的能力推动了广泛采用。随着对个人化和高效给药的需求不断增长，整合设备正在成为医疗保健提供者和患者的首选，特别是在管理糖尿病和气喘等慢性病方面。

根据给药途径：肠胃外和吸入。注射给药领域在联网给药设备市场中占据主导地位。糖尿病等慢性病的高盛行率以及连网胰岛素笔等自我管理设备的日益普及推动了这一主导地位。肠外设备透过即时资料追踪提供精确的剂量、易用性并增强患者的依从性。此外，需要注射给药的生物製剂的增加进一步增加了对连网注射设备的需求，巩固了其在市场上的领先地位。

依应用分类：气喘、慢性阻塞性肺病、糖尿病管理及其他（自体免疫疾病、多发性硬化症等）。糖尿病管理领域主导互联给药设备市场。这是由于全球糖尿病盛行率不断上升以及智慧胰岛素笔和血糖监测系统的日益普及。这些设备可以更好地遵守治疗计划、即时监测和资料共享功能，从而改善患者的治疗效果。随着对数位健康技术的投资不断增加以及对个人化护理的关注，糖尿病管理继续推动该市场的大部分需求。

互联药物传输设备市场 - 地理洞察

连网给药设备市场在北美、欧洲、亚太地区、拉丁美洲以及中东和非洲呈现强劲成长。北美因其先进的医疗基础设施、数位健康解决方案的高采用率以及糖尿病和哮喘等慢性病的庞大患者群体而处于领先地位。欧洲紧随其后，在医疗保健数位化和老年人口不断增长方面进行了大量投资。同时，在医疗保健投资增加、智慧型手机使用量增加以及连网设备使用范围扩大的推动下，亚太地区呈现快速成长。拉丁美洲、中东和非洲的新兴经济体也因改善医疗服务而展现出潜力。

连网药物输送设备市场-竞争格局：

联网给药设备市场竞争激烈，主要参与者专注于创新和策略合作。 Propeller Health、Phillips-Medisize、Teva Pharmaceuticals 和 Aderium 等公司正在利用智慧技术来增强患者的依从性和监测。製药公司和科技公司之间的合作正在推动先进设备的开发。新创公司也透过人工智慧解决方案进入市场，加剧了竞争。此外，参与者正在投资研发以满足监管要求并提高可用性。采用连网设备来管理慢性病进一步加剧了这个充满活力的市场的竞争。

最新进展：

2022 年 2 月，AptarGroup Inc. 推出了 HeroTracker Sense，这是一种数位解决方案，可将传统的计量吸入器转变为智慧型设备，以增强药物管理，特别是针对气喘和慢性阻塞性肺病患者。该工具与 BreatheSmart 应用程式集成，提高依从性和疾病管理。

目录

第 1 章：连网药物输送设备市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的互联药物传输设备市场片段
    • 按应用分類的连网药物传输设备市场片段
    • 依给药途径分類的互联药物输送设备市场片段
    • 按国家/地区分類的连网药物输送设备市场片段
    • 按地区分類的连网药物传输设备市场片段
  • 竞争洞察

第 3 章：联网给药设备主要市场趋势

  • 联网给药设备市场驱动因素
    • 市场驱动因素的影响分析
  • 连网给药设备市场限制
    • 市场限制影响分析
  • 联网给药设备市场机会
  • 连网给药设备市场未来趋势

第 4 章：联网给药设备产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：连网药物输送设备市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：连网药物输送设备市场格局

  • 2023 年连网给药设备市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：连网药物输送设备市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 独立组件
    • 软体和整合设备

第 8 章：连网药物输送设备市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 慢性阻塞性肺病
    • 糖尿病管理
    • 其他（自体免疫疾病、多发性硬化症等）

第 9 章：互联药物输送设备市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 注射用
    • 吸入式

第 10 章：连网药物输送设备市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 连网给药设备北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模与预测（按管理途径）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲连网药物传输设备主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按管理途径）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区连网给药设备主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（依管理途径）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲连网药物传输设备主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 互联药物传输设备中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按管理途径）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 连网药物输送设备产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Phillips-Medisize (a Molex company)
    • BD (Becton, Dickinson and Company)
    • West Pharmaceutical Services, Inc.
    • Ypsomed AG
    • Novo Nordisk A/S
    • Propeller Health (a ResMed company)
    • Adherium Limited
    • Sensirion AG
    • Cohero Health (a Teva Pharmaceuticals subsidiary)
    • AptarGroup, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4330

REPORT HIGHLIGHT

Connected Drug Delivery Devices Market size was valued at USD 5,123.45 Billion in 2023, expanding at a CAGR of 23.5% from 2024 to 2032.

Connected drug delivery devices integrate advanced digital technology with traditional drug delivery systems to enhance patient care. These devices enable real-time monitoring, data sharing, and adherence tracking, offering personalized treatment options. Commonly used in chronic disease management, they support conditions like diabetes, asthma, and cardiovascular disorders. With features such as Bluetooth connectivity and smartphone integration, connected drug delivery devices improve therapeutic outcomes while empowering patients and healthcare providers with actionable insights for better disease management.

Connected Drug Delivery Devices Market- Market Dynamics

Increasing Demand for Smart and Efficient Drug Delivery Solutions

The increasing prevalence of chronic diseases, such as diabetes and asthma, is driving demand for connected drug delivery devices. These devices enhance patient adherence by providing real-time monitoring, reminders, and feedback through digital platforms. Rising awareness about personalized medicine and the integration of IoT in healthcare are further boosting their adoption. Technological advancements, including wireless connectivity and mobile applications, improve treatment outcomes by enabling remote monitoring for healthcare professionals. Additionally, growing investments in smart healthcare solutions and the push for home-based care are fueling the market, addressing the need for effective and efficient drug administration systems globally.

Connected Drug Delivery Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 23.5% over the forecast period (2024-2032)

Based on Product Type segmentation, the integrated devices segment was predicted to show maximum market share in the year 2023

Based on application segmentation, the diabetes segment was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Connected Drug Delivery Devices Market- Segmentation Analysis:

The Global Connected Drug Delivery Devices Market is segmented based on Product Type, Application, Route of Administration, and Region. The market is divided into three categories based on Product Type: Standalone Components & Software and Integrated Devices. The Integrated Devices segment dominates the Connected Drug Delivery Devices Market. These devices combine drug delivery mechanisms with built-in connectivity features, enabling seamless tracking, monitoring, and data sharing in real-time. Their convenience, improved patient adherence, and ability to integrate into digital healthcare systems have driven widespread adoption. With the growing demand for personalized and efficient drug administration, integrated devices are becoming the preferred choice among healthcare providers and patients, particularly in managing chronic conditions like diabetes and asthma.

Based on route of administration: Parenteral and Inhalational. The parenteral segment dominates the Connected Drug Delivery Devices Market. The high prevalence of chronic diseases like diabetes and the increasing adoption of self-administration devices such as connected insulin pens drive this dominance. Parenteral devices offer precise dosing, ease of use, and enhanced patient compliance through real-time data tracking. Additionally, the rise in biologics requiring injection-based delivery further boosts demand for connected parenteral devices, solidifying their leading position in the market.

By application: Asthma, COPD, Diabetes Management and Others (autoimmune diseases, multiple sclerosis, etc.). The Diabetes Management segment dominates the Connected Drug Delivery Devices Market. This is attributed to the rising prevalence of diabetes globally and the increasing adoption of smart insulin pens and glucose monitoring systems. These devices offer improved adherence to treatment plans, real-time monitoring, and data sharing capabilities, enhancing patient outcomes. With growing investments in digital health technologies and a focus on personalized care, diabetes management continues to drive the majority of the demand in this market.

Connected Drug Delivery Devices Market- Geographical Insights

The Connected Drug Delivery Devices Market shows strong growth across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads due to its advanced healthcare infrastructure, high adoption rates of digital health solutions, and a large patient base for chronic conditions like diabetes and asthma. Europe follows with significant investments in healthcare digitalization and a growing elderly population. Meanwhile, Asia-Pacific exhibits rapid growth driven by increasing healthcare investments, rising smartphone usage, and expanding access to connected devices. Emerging economies in Latin America and the Middle East & Africa also display potential due to improving healthcare access.

Connected Drug Delivery Devices Market- Competitive Landscape:

The Connected Drug Delivery Devices Market is highly competitive, with key players focusing on innovation and strategic collaborations. Companies such as Propeller Health, Phillips-Medisize, Teva Pharmaceuticals, and Adherium are leveraging smart technology to enhance patient adherence and monitoring. Partnerships between pharmaceutical firms and tech companies are driving the development of advanced devices. Startups are also entering the market with AI-enabled solutions, intensifying competition. Additionally, players are investing in R&D to meet regulatory requirements and improve usability. The adoption of connected devices in managing chronic diseases is further accelerating competition in this dynamic market.

Recent Developments:

In February 2022, AptarGroup Inc. introduced the HeroTracker Sense, a digital solution that transforms traditional metered-dose inhalers into smart devices for enhanced medication management, particularly for asthma and COPD patients. This tool integrates with the BreatheSmart app, improving adherence and disease management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Phillips-Medisize (a Molex company)
  • BD (Becton, Dickinson and Company)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Novo Nordisk A/S
  • Propeller Health (a ResMed company)
  • Adherium Limited
  • Sensirion AG
  • Cohero Health (a Teva Pharmaceuticals subsidiary)
  • AptarGroup, Inc.
  • Others

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Standalone Components
  • Software and Integrated Devices

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Asthma
  • COPD
  • Diabetes Management
  • Others (autoimmune diseases, multiple sclerosis, etc.)

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Parenteral
  • Inhalational

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Connected Drug Delivery Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Connected Drug Delivery Devices Market Snippet by Product Type
    • 2.1.2. Connected Drug Delivery Devices Market Snippet by Application
    • 2.1.3. Connected Drug Delivery Devices Market Snippet by Route of Administration
    • 2.1.4. Connected Drug Delivery Devices Market Snippet by Country
    • 2.1.5. Connected Drug Delivery Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Connected Drug Delivery Devices Key Market Trends

  • 3.1. Connected Drug Delivery Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Connected Drug Delivery Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Connected Drug Delivery Devices Market Opportunities
  • 3.4. Connected Drug Delivery Devices Market Future Trends

4. Connected Drug Delivery Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Connected Drug Delivery Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Connected Drug Delivery Devices Market Landscape

  • 6.1. Connected Drug Delivery Devices Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Connected Drug Delivery Devices Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Standalone Components
    • 7.1.3. Software and Integrated Devices

8. Connected Drug Delivery Devices Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. COPD
    • 8.1.3. Diabetes Management
    • 8.1.4. Others (autoimmune diseases, multiple sclerosis, etc.)

9. Connected Drug Delivery Devices Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Parenteral
    • 9.1.3. Inhalational

10. Connected Drug Delivery Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Connected Drug Delivery Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Connected Drug Delivery Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Connected Drug Delivery Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Connected Drug Delivery Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Connected Drug Delivery Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Connected Drug Delivery Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Phillips-Medisize (a Molex company)
    • 11.2.2. BD (Becton, Dickinson and Company)
    • 11.2.3. West Pharmaceutical Services, Inc.
    • 11.2.4. Ypsomed AG
    • 11.2.5. Novo Nordisk A/S
    • 11.2.6. Propeller Health (a ResMed company)
    • 11.2.7. Adherium Limited
    • 11.2.8. Sensirion AG
    • 11.2.9. Cohero Health (a Teva Pharmaceuticals subsidiary)
    • 11.2.10. AptarGroup, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us